Source link : https://news7.asia/news/lotte-biologics-accelerates-global-expansion-with-cutting-edge-manufacturing-hubs-and-next-gen-adc-technologies-in-north-america-and-asia/
LOTTE BIOLOGICS is making a significant move to strengthen its position in the global contract development and manufacturing organization (CDMO) market by establishing dual manufacturing bases across North America and Asia. This strategic expansion is complemented by the company’s focus on advancing next-generation antibody-drug conjugate (ADC) modalities, aiming to meet the rising demand for innovative biologics and personalized therapies worldwide. Industry experts view LOTTE BIOLOGICS’ bold initiatives as a pivotal step in enhancing global supply chain resilience and accelerating the development of cutting-edge biopharmaceuticals.
LOTTE BIOLOGICS Strengthens Global Footprint with New Manufacturing Facilities in North America and Asia
LOTTE BIOLOGICS is making significant strides in expanding its Contract Development and Manufacturing Organization (CDMO) capabilities by establishing state-of-the-art manufacturing facilities strategically located in North America and Asia. These new bases are set to enhance the company’s ability to cater to a broader range of biopharmaceutical clients, accelerating the delivery of complex biologics with improved efficiency and scalability. The move addresses the rising global demand for advanced biologics manufacturing, underlining LOTTE BIOLOGICS’ commitment to becoming a pivotal player in the global biopharma supply chain.
In addition to expanding geographic reach, LOTTE BIOLOGICS is pushing the boundaries of…
—-
Author : Victoria Jones
Publish date : 2025-08-04 13:46:00
Copyright for syndicated content belongs to the linked Source.
—-
1 – 2 – 3 – 4 – 5 – 6 – 7 – 8